Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Globus Medical, Inc. operates as a medical device ... It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical ...

Globus Medical, Inc. GMED continues to benefit from ... the combined company has formed a global musculoskeletal company focused on rapid innovation, addressing unmet clinical needs, and improving ...

The ascent to this record price level reflects strong market confidence in Globus Medical's innovative product offerings and strategic initiatives, which continue to propel the company forward in ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...

Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.4% on an annualized basis producing an average annual return of 11.03%. Currently, Globus Medical has a market ...

In the preceding three months, 5 analysts have released ratings for Globus Medical (NYSE:GMED), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...